D. E. Shaw & Co., Inc. - APTEVO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$370,000
-75.5%
291,582
-1.9%
0.00%
-50.0%
Q3 2018$1,510,000
-4.6%
297,254
-6.2%
0.00%0.0%
Q2 2018$1,582,000
+70.7%
316,977
+11.8%
0.00%
+100.0%
Q1 2018$927,000
-32.7%
283,626
-12.8%
0.00%
-50.0%
Q4 2017$1,378,000
+69.7%
325,085
-8.3%
0.00%
+100.0%
Q3 2017$812,000
+24.2%
354,483
+12.2%
0.00%0.0%
Q2 2017$654,000
-4.2%
315,970
-4.6%
0.00%0.0%
Q1 2017$683,000
-13.9%
331,344
+2.0%
0.00%0.0%
Q4 2016$793,000
-17.6%
324,828
-13.5%
0.00%
-50.0%
Q3 2016$962,000375,6580.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 974,492$2,495,0000.55%
Perceptive Advisors 988,133$2,530,0000.16%
STRATEGIC INVESTMENT MANAGEMENT, LLC 38,860$99,0000.07%
Laurel Wealth Advisors, Inc. 42,890$110,0000.05%
CSS LLC/IL 353,977$906,0000.04%
GLG Partners LP 396,486$1,015,0000.03%
Capital Impact Advisors, LLC 12,318$32,0000.01%
Spark Investment Management LLC 66,000$168,0000.01%
Peak Asset Management, LLC 10,000$26,0000.01%
OXFORD ASSET MANAGEMENT LLP 99,390$254,0000.01%
View complete list of APTEVO THERAPEUTICS INC shareholders